| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.DRUDIS.2006.04.014 |
| P698 | PubMed publication ID | 16713900 |
| P2093 | author name string | Steven E Hall | |
| P433 | issue | 11-12 | |
| P921 | main subject | drug discovery | Q1418791 |
| P304 | page(s) | 495-502 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Drug Discovery Today | Q3040085 |
| P1476 | title | Chemoproteomics-driven drug discovery: addressing high attrition rates | |
| P478 | volume | 11 |
| Q36329722 | A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules |
| Q38165926 | A Functional Proteomics Perspective of DBC1 as a Regulator of Transcription |
| Q39017913 | An Integrated In Silico Approach for the Structural and Functional Exploration of Lipocalin 2 and its Functional Insights with Metalloproteinase 9 and Lipoprotein Receptor-Related Protein 2. |
| Q37234005 | Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care. |
| Q39731911 | Fragment-based lead discovery: challenges and opportunities |
| Q28472011 | Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data |
| Q30367299 | Method for comparing the structures of protein ligand-binding sites and application for predicting protein-drug interactions. |
| Q37886999 | Nano-enabled biomarker discovery and detection |
| Q34005966 | Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors |
| Q38089202 | Small-molecule affinity chromatography coupled mass spectrometry for drug target deconvolution |
| Q39169235 | Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery |
| Q48070614 | The discovery of first-in-class drugs: origins and evolution. |
Search more.